We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+28.39%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$5.06B
AUM Growth
+$953M
Cap. Flow
+$556M
Cap. Flow %
10.99%
Top 10 Hldgs %
34.58%
Holding
150
New
52
Increased
21
Reduced
21
Closed
24

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$116M
2
ONCR
Oncorus, Inc.
ONCR
+$66M
3
TOI icon
The Oncology Institute
TOI
+$56.2M
4
CYTK icon
Cytokinetics
CYTK
+$45M
5
VTRS icon
Viatris
VTRS
+$40M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$196M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$142M
3
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$96M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$74.4M
5
DFPHU
DFP Healthcare Acquisitions Corp. Unit
DFPHU
+$58.3M

Sector Composition

Rank Sector Weight
1 Healthcare 69.84%
2 Industrials 0.55%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCRX icon
26
BioCryst Pharmaceuticals
BCRX
$2.43B
$43.5M 0.86%
5,835,810
+1,379,291
+31% +$7.11M
CNST
27
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$42M 0.83%
1,458,957
+453,470
+45% +$11.4M
PBYI icon
28
Puma Biotechnology
PBYI
$407M
$40.6M 0.8%
3,959,741
+1,133,414
+40% +$11.5M
VIVO
29
DELISTED
Meridian Bioscience Inc
VIVO
$40.4M 0.8%
2,161,000
+652,602
+43% +$12.2M
BDSI
30
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$40M 0.79%
9,530,000
+1,894,250
+25% +$7.3M
AXNX
31
DELISTED
Axonics, Inc. Common Stock
AXNX
$39.9M 0.79%
800,000
+24,000
+3% +$1.13M
ISEE
32
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$39.9M 0.79%
5,767,409
– –
RETA
33
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$39.6M 0.78%
320,000
-128,000
-29% -$16.8M
QDEL icon
34
QuidelOrtho
QDEL
$1.15B
$39.5M 0.78%
220,000
+89,479
+69% +$19.9M
EDIT icon
35
Editas Medicine
EDIT
$410M
$37.8M 0.75%
538,721
-450,120
-46% -$18.5M
OLMA icon
36
Olema Pharmaceuticals
OLMA
$1.05B
$33.5M 0.66%
+696,191
New +$32.6M
LUMO
37
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$33.4M 0.66%
936,291
– –
LUNG icon
38
Pulmonx
LUNG
$51.5M
$32M 0.63%
+463,511
New +$22.7M
NUVA
39
DELISTED
NuVasive, Inc.
NUVA
$31.8M 0.63%
+565,000
New +$27.8M
SHC icon
40
Sotera Health
SHC
$4.92B
$30.5M 0.6%
+1,111,000
New +$29.8M
DCPH
41
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$30.2M 0.6%
528,585
– –
ORTX
42
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$30M 0.59%
694,942
– –
KOD icon
43
Kodiak Sciences
KOD
$2.63B
$29.7M 0.59%
202,406
-294,594
-59% -$32.8M
ACH
44
Accendra Health
ACH
$246M
$29.6M 0.59%
1,096,000
-381,000
-26% -$9.8M
ANNX icon
45
Annexon
ANNX
$841M
$29.2M 0.58%
1,167,826
-450,000
-28% -$11.6M
ATEC icon
46
Alphatec Holdings
ATEC
$1.33B
$29M 0.57%
+2,000,000
New +$21.1M
STTK icon
47
Shattuck Labs
STTK
$672M
$28.8M 0.57%
+550,000
New +$17.7M
PTGX icon
48
Protagonist Therapeutics
PTGX
$8.72B
$27.8M 0.55%
1,379,971
+200,000
+17% +$4.3M
ACCD
49
DELISTED
Accolade Inc
ACCD
$27.8M 0.55%
638,001
+14,000
+2% +$622K
GBIO
50
DELISTED
Generation Bio
GBIO
$27.3M 0.54%
96,122
– –
1
2
3 4 5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q4 2020 Portfolio in Review

As of Q4 2020, Deerfield Management held 150 positions worth $5.06B, up 23% from $4.11B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Deerfield Management deployed $556M of net new capital in Q4 2020, opening 52 new positions and adding to 21 existing holdings. Its largest new stake was Biogen: 448,000 shares worth $110M.

By sector, the portfolio is most concentrated in Healthcare at 70% of assets, up from 62% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was DFP Healthcare Acquisitions Corp. Unit, an estimated $58.3M trimmed.

  • Deerfield Management's largest Q4 2020 buy was Biogen: 448,000 shares worth $110M.
  • Deerfield Management added most to Viatris in Q4 2020, an estimated $40M increase.
  • Deerfield Management's biggest Q4 2020 reduction was DFP Healthcare Acquisitions Corp. Unit, cutting an estimated $58.3M.
  • Deerfield Management fully exited Immunomedics Inc in Q4 2020, selling an estimated $196M.
  • Deerfield Management's ten largest holdings make up 35% of its $5.06B portfolio in Q4 2020.
  • Deerfield Management opened 52 new positions and closed 24 in Q4 2020.
  • Deerfield Management's portfolio value rose 23% quarter-over-quarter to $5.06B.

Based on Deerfield Management's 13F filing for Q4 2020, filed 16 Feb 2021.